149 related articles for article (PubMed ID: 9257901)
1. P2-receptor modulation of noradrenergic neurotransmission in rat kidney.
Bohmann C; von Kügelgen I; Rump LC
Br J Pharmacol; 1997 Aug; 121(7):1255-62. PubMed ID: 9257901
[TBL] [Abstract][Full Text] [Related]
2. P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus.
Koch H; von Kügelgen I; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):707-15. PubMed ID: 9205954
[TBL] [Abstract][Full Text] [Related]
3. P2-purinoceptor-mediated inhibition of noradrenaline release in rat atria.
von Kügelgen I; Stoffel D; Starke K
Br J Pharmacol; 1995 May; 115(2):247-54. PubMed ID: 7670726
[TBL] [Abstract][Full Text] [Related]
4. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
von Kügelgen I; Späth L; Starke K
Br J Pharmacol; 1994 Nov; 113(3):815-22. PubMed ID: 7858872
[TBL] [Abstract][Full Text] [Related]
5. P2-receptor-mediated inhibition of noradrenaline release in the rat pancreas.
Koch H; von Kügelgen I; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):431-40. PubMed ID: 9606030
[TBL] [Abstract][Full Text] [Related]
6. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
Rump LC; Schollmeyer P
Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats.
Rump LC; Wilde K; Schollmeyer P
J Hypertens; 1990 Oct; 8(10):897-908. PubMed ID: 2174941
[TBL] [Abstract][Full Text] [Related]
8. Noradrenaline and extracellular nucleotide cotransmission involves activation of vasoconstrictive P2X(1,3)- and P2Y6-like receptors in mouse perfused kidney.
Vonend O; Stegbauer J; Sojka J; Habbel S; Quack I; Robaye B; Boeynaems JM; Rump LC
Br J Pharmacol; 2005 May; 145(1):66-74. PubMed ID: 15711586
[TBL] [Abstract][Full Text] [Related]
9. ATP and endogenous agonists inhibit evoked [3H]-noradrenaline release in rat iris via A1 and P2y-like purinoceptors.
Fuder H; Muth U
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):352-7. PubMed ID: 8277974
[TBL] [Abstract][Full Text] [Related]
10. Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptors.
Kurz K; von Kügelgen I; Starke K
Br J Pharmacol; 1993 Dec; 110(4):1465-72. PubMed ID: 8306088
[TBL] [Abstract][Full Text] [Related]
11. A study of ATP as a sympathetic cotransmitter in human saphenous vein.
Rump LC; von Kügelgen I
Br J Pharmacol; 1994 Jan; 111(1):65-72. PubMed ID: 7912156
[TBL] [Abstract][Full Text] [Related]
12. ATP modulates the release of noradrenaline through two different prejunctional receptors on the adrenergic nerves of rat prostate.
Morikawa T; Tanaka N; Kubota Y; Mizuno H; Nakamura K; Kunitomo M; Shinozuka K
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):601-5. PubMed ID: 17581215
[TBL] [Abstract][Full Text] [Related]
13. Local regulation of [(3)H]-noradrenaline release from the isolated guinea-pig right atrium by P(2X)-receptors located on axon terminals.
Sperlágh B; Erdélyi F; Szabó G; Vizi ES
Br J Pharmacol; 2000 Dec; 131(8):1775-83. PubMed ID: 11139458
[TBL] [Abstract][Full Text] [Related]
14. Alpha-adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats.
Bohmann C; Rump LC; Schaible U; von Kügelgen I
Hypertension; 1995 Jun; 25(6):1224-31. PubMed ID: 7768566
[TBL] [Abstract][Full Text] [Related]
15. Purinoceptor modulation of noradrenaline release in rat tail artery: tonic modulation mediated by inhibitory P2Y- and facilitatory A2A-purinoceptors.
Gonçalves J; Queiroz G
Br J Pharmacol; 1996 Jan; 117(1):156-60. PubMed ID: 8825357
[TBL] [Abstract][Full Text] [Related]
16. Role of action potentials and calcium influx in ATP- and UDP-induced noradrenaline release from rat cultured sympathetic neurones.
von Kügelgen I; Nörenberg W; Meyer A; Illes P; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1999 May; 359(5):360-9. PubMed ID: 10498285
[TBL] [Abstract][Full Text] [Related]
17. Effects of GABA on noradrenaline release and vasoconstriction induced by renal nerve stimulation in isolated perfused rat kidney.
Fujimura S; Shimakage H; Tanioka H; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Br J Pharmacol; 1999 May; 127(1):109-14. PubMed ID: 10369462
[TBL] [Abstract][Full Text] [Related]
18. Prominent sympathetic purinergic vasoconstriction in the rabbit splenic artery: potentiation by 2,2'-pyridylisatogen tosylate.
Ren LM; Burnstock G
Br J Pharmacol; 1997 Feb; 120(3):530-6. PubMed ID: 9031760
[TBL] [Abstract][Full Text] [Related]
19. Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.
Rump LC; Wilde K; Bohmann C; Schollmeyer P
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):300-8. PubMed ID: 1352381
[TBL] [Abstract][Full Text] [Related]
20. P2-receptor-mediated inhibition of serotonin release in the rat brain cortex.
von Kügelgen I; Koch H; Starke K
Neuropharmacology; 1997 Sep; 36(9):1221-7. PubMed ID: 9364477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
